Sage Journals: Discover world-class research

Open access

Research article

First published 2023

PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis

Yoram Bouhnik, Bruno Fautrel, Laurent Beaugerie [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2016-11

Detection of anti-infliximab antibodies is impacted by antibody titer,infliximab level and IgG4 antibodies: a systematic comparison of three different assays

Joana Afonso, Susana Lopes, Raquel Gonçalves [...]

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2019

The ‘totality-of-the-evidence’ approach in the development of PF-06438179/GP1111,an infliximab biosimilar,and in support of its use in all indications of the reference product

Joseph E. McClellan, Hugh D. Conlon, Michael W. Bolt [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2020-5

Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis

Hillary Moore, Pasquale Dolce, Nina Devas [...]

United European Gastroenterology Journal

Open access

Research article

First published 2022

Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study

Aviv Pudipeddi, Yanna Ko, Sudarshan Paramsothy [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2024

Infliximab monitoring in Crohn’s disease: a neural network approach for evaluating disease activity and immunogenicity

Luis Eduardo Miani Gomes, Livia Moreira Genaro, Marina Moreira de Castro [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2024

Effectiveness comparison between ustekinumab and infliximab for Crohn’s disease complicated with intestinal stenosis: a multicenter real-world study

Xidong He, Yufang Wang, Jingyao Sun [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

Dynamics of serum concentrations of antibodies to infliximab: a new approach for predicting secondary loss of response in inflammatory bowel diseases

Melina K. Grasmeier, Anna F. Langmann, Peter Langmann [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2019-11

Short note: Infliximab recovery in a simulated intestinal fluid of the upper intestine tract

Donatella Volpatti, Eleonora Gulisano, Mauro Spanghero

Human Antibodies

Open access

Research article

First published 2017-9

Clinical performance of an infliximab rapid quantification assay

Fernando Magro, Joana Afonso, Susana Lopes [...]

Therapeutic Advances in Gastroenterology

Search results